A RISING MMA star has been arrested on child sex crime allegations just days before he was set to make his UFC debut. Ahmad ...

An investment strategist has highlighted three companies driving the “new age” of healthcare, making them must-watch for ...

More and more folks are becoming cannabis-curious when it comes to weed for medical conditions. Researchers, too, are hopping ...

Oddity delivers standout growth and efficiency via AI, customer data, and direct sales, even with early-stage biotech risk.

Hims & Hers Health (HIMS) has emerged as a disruptive force in telehealth, leveraging technology and personalization to address highly-personal health conditions while achieving scalable profitability ...

Hims & Hers Health stock is trading -39.24% below its average target price of $44.82 after marking a 1.0% during today's ...

Some research suggests that a man’s drive tends to decline with age. One study found that the drive of middle-aged men (40–60 ...

Eli Lilly and Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot.

The company's breakthrough puts the market one step closer to having an injection-free alternative for the treatment of ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

Pharma advertisers have kicked off 2025 with a bang, with the top 10 spenders throwing almost 30% more money behind their TV commercials in the first quarter compared to the same period a year ago. | ...